Together, our data suggested that EGR2 expresses at a low level in the resting T and B lymphocytes and that anti-CD3 and anti-CD28 stimulation significantly induces EGR2 expression in splenic T and B lymphocytes in both control and lupus mice. The gene discussed is EGR2; the disease is systemic lupus erythematosus.